Boston Scientific Payment for (Proceeds from) Other Investing Activity increased by 34.2% to -$48.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1500.0%, from -$3.00M to -$48.00M. Over 4 years (FY 2021 to FY 2025), Payment for (Proceeds from) Other Investing Activity shows relatively stable performance with a 0.6% CAGR.
Fluctuations are typically non-recurring; large values may warrant investigation into specific one-time events.
This captures miscellaneous cash flows related to investing activities that do not fit into standard categories like pro...
Standard line item in cash flow statements for miscellaneous investing adjustments.
investing_payments_for_proceeds_from_other_investing_activities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$21.00M | -$19.00M | -$20.00M | -$19.00M | -$17.00M | -$18.00M | -$16.00M | -$9.00M | -$7.00M | -$7.00M | -$14.00M | -$7.00M | -$5.00M | -$5.00M | -$6.00M | -$3.00M | -$4.00M | -$4.00M | -$73.00M | -$48.00M |
| QoQ Change | — | +9.5% | -5.3% | +5.0% | +10.5% | -5.9% | +11.1% | +43.8% | +22.2% | +0.0% | -100.0% | +50.0% | +28.6% | +0.0% | -20.0% | +50.0% | -33.3% | +0.0% | <-999% | +34.2% |
| YoY Change | — | — | — | — | +19.0% | +5.3% | +20.0% | +52.6% | +58.8% | +61.1% | +12.5% | +22.2% | +28.6% | +28.6% | +57.1% | +57.1% | +20.0% | +20.0% | <-999% | <-999% |